Clindamycin resistance. in Bacteroides fragilis was examined in 507 strains isolated from 1973 to 1981. Three groups were recognized: highly susceptible (minimum inhibitory concentration [MIC] -0.125 ,ug/ml), intermediately susceptible (MIC = 0.25 to 4 ,Lg/ml), and highly resistant (MIC 2 8 ,ug/ml). The incidence of high-level resistance (1.8%) had not changed during this period. Only 8 of 17 isolates reputed to be highly clindamycin resistant that were referred to our laboratory proved to be highly resistant (MICs 2 32 ,ug/ml), whereas the other 9 were intermediately susceptible. Analysis of 2-and 10-,ug clindamycin disks for determining the susceptibility of B. fragilis revealed a high false-resistance rate with the 2-,ug disk, most errors occurring with the intermediate group. There was no false resistance with the 10-,ug disk. When disk diffusion susceptibility of B. fragilis is employed, we recommend the 10-,ug disk to predict accurately the susceptibility of B. fragilis to clindamycin.
Clindamycin is an important antimicrobial agent for the therapy of anaerobic infections because of its consistent activity against Bacteroides fragilis and other pathogenic anaerobic bacteria (3) . Since the early 1970s, there has been relatively little resistance to clindamycin among these organisms (6, 10) . Recent studies from four hospitals in Detroit, Mich., however, have reported 15 to 20% incidence of clindamycin resistance in Bacteroides species (1). Furthermore, three laboratories have documented transferable clindamycin resistance in these organisms (7, 16, 18) . These observations suggest that antimicrobial resistance in Bacteroides species should be monitored closely in clinical microbiology laboratories.
A problem in such monitoring has been the lack of a standardized susceptibility method for anaerobic bacteria and the great variability among the methods described, i.e., disk diffusion, disk broth dilution, agar dilution, and broth dilution. Many laboratories utilize the BauerKirby method of disk diffusion for testing aerobic and facultative bacteria, and this test has been applied to anaerobic bacteria as well (2, 12). Unfortunately, the disk diffusion method, when applied to anaerobic microorganisms, has many limitations (14) . In addition to the inherent technical problems, the content of clindamycin in the disk is an issue. The 2-g clindamycin disk has U.S. Food and Drug Administration approval for routine susceptibility testing, but we have found that it gives a falsely high rate of clindamycin resistance in B. fragilis. Seventeen Bacteroides isolates were referred to us from other hospitals for presumed resistance to clindamycin. These strains were reidentified, and their antimicrobial susceptibility was tested.
Susceptibility tests. MICs were determined by a modified agar dilution method by using Steer's replicator to inoculate approximately 104 colony-forming units per spot onto brain heart infusion agar supplemented with 5% laked sheep blood and vitamin K (10 iag/ml) (2, 11). The inoculum was incubated for 4 to 6 h in supplemented brain heart infusion broth. Anaerobic chamber techniques with an atmosphere of 85% Nz10%o H2-5% CO2 were used throughout (15 Analysis of referred strains. Seventeen isolates of the B. fragilis group were referred to our laboratory from 1978 to 1980. These strains had been characterized as resistant by the disk diffusion technique with a 2-,ug clindamycin disk. Clindamycin resistance was confirmed in eight strains, for which the MICs were greater than 32 ,ug/ml. The remaining nine strains had MICs ranging from 0.125 to 2 ,ug/ml; this range would be considered indicative of susceptibility to clindamycin, based on achievable blood levels.
Disk diffusion as a method to predict susceptibility. The comparison of suceptibility by MIC and by agar diffusion with 2-and 10-,ug disks is given on Table 2 . Ninety-five percent of highly susceptible strains (MIC < 0.125) were predicted with the 2-p,g disk, resulting in false prediction of resistance of 5%. When the 10-lg disk was used, the prediction of susceptibility was 100%o. The susceptibility of only 30%o of the intermediately susceptible group (MIC = 0.25 to 4 ,g/ml) could be predicted with the 2-,ug disk, whereas the 10-,ug disk gave 100% predictability in this group. The organisms in this intermediate group that appeared susceptible with the 2-,ug disk usually had a MIC of about 0.25 ,ug/ml, whereas those with MICs of 0.5 to 4 ,ug/ml usually gave zone sizes of less than 15 mm, thereby seeming to be resistant. When resistant organisms (MIC -8 ,ug/ml) were tested, there was no false susceptibility with the 2-or 10-,ug disks. Figure 1 shows the analysis of these data by the error rate-bounded method, with a 15-mmdiameter zone of inhibition as the breakpoint for susceptibility with a 10-Rg disk. With this break- (5, 17, 19) . It is known that such genetic systems in aerobic bacteria are responsible for increased resistance of these organisms to multiple antibiotics; therefore, it should be anticipated that antibiotic pressure will produce an increasing resistance to clindamycin in Bacteroides species.
Since erythromycin also stimulates clindamycin resistance (9, 17) Our analysis of these Bacteroides strains suggests that they fall into three groups: highly susceptible, intermediately susceptible, and highly resistant. Although the number of strains in the intermediate group is relatively small, these organisms are frequently labeled resistant to clindamycin with the 2-,ug disk, when they are actually susceptible to achievable drug levels. The 2-,ug disk appears to be inadequate for testing B. fragilis susceptibility, and efforts should be made to obtain 10-Rxg disks for such testing.
Alternatives to the disk method are the broth disk elution method, agar dilution, or the MIC determination by macro-or microbroth dilution. These techniques are suitable for determining the susceptibility of B. fragilis to clindamycin. The currently recommended method of the National Committee for Clinical Laboratory Standards is a modification of the agar dilution method in which the different variables of the test are carefully controlled (8) . Our current practice is to use either agar dilution or the microbroth dilution technique to determine the susceptibility of clinical isolates. Whatever method is chosen to determine the susceptibility of Bacteroides species, the test should be run with appropriate controls and should be correlated with an accepted reference method, such as agar dilution. 
